Please provide your email address to receive an email when new articles are posted on . Metformin lowered the risk for long COVID in adults with overweight or obesity across several analyses. More ...

Metformin, long trusted for diabetes, turns out to work in the brain too. By shutting down Rap1 in the hypothalamus, the drug lowers blood sugar more effectively than previously understood, opening ...

NEW YORK, Aug. 25 (UPI) --Medical science continues to develop new and innovative ways to boost health and well-being, but a relatively old drug -- metformin -- may hold the key to human longevity and ...

Metformin is a generic prescription drug that works to treat type 2 diabetes by helping lower your blood sugar levels. Your response to this drug may vary based on your medical history and diagnosis.

Metformin is an unassuming hero of modern medicine. For more than 60 years, this humble pill has been a mainstay of diabetes care, helping millions of people manage their blood sugar. It lowers blood ...

In a recent study published in the journal Science Advances, researchers tested whether low, clinically relevant doses of metformin lower blood glucose via inhibition of Ras-related protein 1 (Rap1) ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works. Scientists at Baylor College of ...

Please provide your email address to receive an email when new articles are posted on . Metformin yielded reductions in knee pain associated with OA vs. placebo. Patients with overweight or obesity ...

DEAR DR. ROACH: I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for weight loss as an alternative to starting Ozempic or one ...

The payments, part of the new domestic policy law, are for U.S. citizens born this year through 2028. The idea is that the money in the accounts will have many years to grow. By Ann Carrns American ...

Adding anagliptin, a DPP-4 inhibitor, to ongoing insulin and metformin therapy was well-tolerated and improved glycemic control at 24 weeks in patients with inadequately controlled type 2 diabetes ...

Metformin use in mCRC patients improved PFS during first-line 5-fluorouracil-based chemotherapy, but no OS benefit was observed. The study suggests metformin's potential as an adjunct therapy in mCRC, ...